Collagen Matrix Names Charles (Chip) Ross as Vice President, Human Resources

We are pleased to announce the appointment of Charles (Chip) Ross as Vice President of Human Resources at Collagen Matrix, Inc. Mr. Ross joined Collagen Matrix in December 2022. Chip brings 30+ years of human resources leadership experience across multiple industries and organizations, with focus in talent development, organizational effectiveness and culture planning.

Prior to joining Collagen Matrix, Chip served as Senior Vice President- Human Resources for MANA Products, a private-equity-owned contract manufacturer of beauty products. He led critical projects to ensure 90+% employee retention by focusing on employee engagement, leadership development and organizational planning.

Previously, Chip held human resources and talent leadership roles at Avon, Parker Health and Merck Pharmaceuticals, including their Medco subsidiary, where he successfully led the people aspects of the world’s first automated pharmacy. He has also been an independent consultant for various organizations, specializing in organizational change and transformation, talent and organizational planning, Human Resources transformation and change management/communications. He holds a Bachelor’s degree in English from West Chester University and a Master’s degree in Teaching from Fordham University. He is a Hogan and Predictive Index certified assessor and is a certified DDI trainer.

Chip is responsible for leading our complete Human Resources function for both the US and the Netherlands teams.

About Collagen Matrix, Inc.

Collagen Matrix, Inc. is a developer and manufacturer of collagen-based medical products used for tissue and bone repair and regeneration. Founded in 1997, Collagen Matrix is headquartered in Oakland, New Jersey and develops proprietary products that are sold to OEM customers on either a contract or private label basis across orthopedic, sports medicine, dental, and neurosurgery end markets. The company also offers partnership opportunities including distribution, contract product development, and contract manufacturing services. For more information, please visit

About Linden Capital Partners

Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare industry. Founded in 2004, Linden is one of the country’s largest dedicated healthcare private equity firms. Linden’s strategy is based upon three elements: (i) healthcare specialization, (ii) integrated private equity and operating expertise, and (iii) its differentiated human capital program. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. Since its founding, Linden has invested in over 40 healthcare companies encompassing over 200 total transactions. The firm has raised over $6 billion in limited partner commitments since inception. For more information, please visit


Looking for a career with purpose? Join our team and work with us to develop life-changing products that help patients heal. Visit our careers page to learn more about what sets Regenity apart.

See open postions

Related posts

Read More

Regenity Capabilities Brochure

Download to learn more about Regenity’s contract development and manufacturing capabilities…

Read More
Read More

Collagen Matrix Inc. Unveils New Brand and Name as Regenity Biosciences

The rebrand supports the company’s position as material transformers in regenerative implant…

Read More
Read More

Vice President of R&D, Dan Ammon, inaugurated into the National Academy of Engineering (NAE)

We are excited to honor and celebrate our Vice President of R&D Dan Ammon and his recent…

Read More

Let’s connect

Learn how to transform patient recovery through unique platforms and processes.